Skip to content

Author

Julia Kacer

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

THE ROLE OF NUTRACEUTICALS IN THE MANAGEMENT OF DYSLIPIDEMIA AND THEIR EFFECTS ON LIPID METABOLISM: A SYSTEMATIC REVIEW

Dyslipidemia is one of the top modifiable causes of ASCVD‚ which is still the leading cause of death worldwide․ Statins are first line treatment‚ but potentially reversible obstacles to effective treatment include patient discontinuation‚ statin intolerance‚ concern about statin-related adverse effects‚ and residual ca...

K. Jurga, Maurycy Jabłoński, Laura Kobaka et al. · 0 citations
Review

Innovative Technologies in Social

Recommendations are made that LDCT screening high-risk populations to reduce lung cancer specific mortality by 16% to 24% and screening protocols should prioritize high-risk individuals‚ regardless of their age or smoking status.

Maurycy Jabłoński, Laura Kobaka, K. Jurga et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.